Key Developments: Quintiles Transnational Holdings Inc (Q.N)

Q.N on New York Stock Exchange

46.29USD
1 Aug 2013
Price Change (% chg)

$1.44 (+3.21%)
Prev Close
$44.85
Open
$46.30
Day's High
$47.49
Day's Low
$45.52
Volume
143,922
Avg. Vol
--
52-wk High
$47.49
52-wk Low
$41.50

Search Stocks

Latest Key Developments (Source: Significant Developments)

Quintiles Transnational Holdings Inc Issues FY 2013 Guidance; EPS Guidance Above Analysts' Estimates
Thursday, 1 Aug 2013 06:00am EDT 

Quintiles Transnational Holdings Inc announced that for fiscal 2013, it expects to achieve service revenues between $3.76 billion and $3.81 billion which represents a constant currency growth range of 3.8% to 5.2%. The Company also expects diluted adjusted earnings per share between $1.95 and $2.05 per share representing growth of 10.2% to 15.5%, diluted GAAP earnings per share between $1.63 and $1.73 per share. This financial guidance is based on the actual results for the first half of 2013 combined with the expected results for the second half of 2013, assuming that June foreign currency exchange rates stay in effect for the remainder of the year. According to I/B/E/S Estimates, analysts were expecting the Company to report revenues of revenues of $3.80 billion and EPS of $1.89 for fiscal 2013.  Full Article

Quintiles Transnational Holdings Inc Announces Pricing Of Initial Public Offering
Wednesday, 8 May 2013 07:40pm EDT 

Quintiles Transnational Holdings Inc announced the pricing of initial public offering of 23,684,210 shares of common stock at a price to the public of $40.00 per share. The shares of Quintiles common stock are expected to begin trading on the New York Stock Exchange under the single-letter symbol Q on May 9, 2013. Quintiles is offering 13,125,000 shares of common stock, and selling shareholders are offering 10,559,210 shares of common stock. In addition, the selling shareholders have granted the underwriters a 30-day option to purchase up to an additional 3,552,631 shares of common stock. The offering is expected to close on May 14, 2013. Morgan Stanley, Barclays and J.P. Morgan are serving as joint lead book-running managers for the offering. Citigroup, Goldman, Sachs & Co., Wells Fargo Securities, BofA Merrill Lynch and Deutsche Bank Securities are serving as book-running managers for the offering. Baird, William Blair and Jefferies are serving as lead co-managers, and Guggenheim Securities, Piper Jaffray, Raymond James, RBC Capital Markets and UBS Investment Bank are serving as co-managers for the offering.  Full Article

Quintiles sees strong profit as drug development picks up

- Quintiles Transnational Holdings, the world's largest medical contract research provider, forecast full-year profit above market expectations as drugmakers looking to launch new products choose to outsource clinical development as a way to cut costs.

Search Stocks